Pages that link to "Q54185982"
Jump to navigation
Jump to search
The following pages link to Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to clinafloxacin. (Q54185982):
Displaying 10 items.
- In Vitro Activities of Clinafloxacin against Contemporary Clinical Bacterial Isolates from 10 North American Centers (Q33696254) (← links)
- Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections (Q33981431) (← links)
- Activities of clinafloxacin, alone and in combination with other compounds, against 45 gram-positive and -negative organisms for which clinafloxacin MICs are high (Q39471785) (← links)
- Comparative Activities of Clinafloxacin against Gram-Positive and -Negative Bacteria (Q39558630) (← links)
- Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models (Q40424644) (← links)
- Beyond vancomycin: new therapies to meet the challenge of glycopeptide resistance (Q41522164) (← links)
- Comparative activity of clinafloxacin and nine other compounds tested against 2000 contemporary clinical isolates from patients in United States hospitals. (Q54074615) (← links)
- Resistance issues and treatment implications: pneumococcus, Staphylococcus aureus, and gram-negative rods. (Q54120809) (← links)
- Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin (Q71848487) (← links)
- In vitro activity of clinafloxacin against fluoroquinolone resistant Spanish clinical isolates (Q77947624) (← links)